Disruption of dopamine homeostasis underlies selective neurodegeneration mediated by α-synuclein

European Journal of Neuroscience

Volumn 26, Issue 11, 2007, Pages 3104-3112

  Park, Soon S ^a   Schulz, Emily M ^a   Lee, Daewoo ^a  

^a OHIO UNIVERSITY   (United States)

Author keywords

Drosophila melanogaster; Mutant human synuclein (A30P); Oxidative stress; Parkinson's disease; Vesicular monoamine transporter

Indexed keywords

ALPHA SYNUCLEIN; DOPAMINE; GREEN FLUORESCENT PROTEIN; METIROSINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CELL LOSS; CONTROLLED STUDY; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; DROSOPHILA; HOMEOSTASIS; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALANINE; ALPHA-METHYLTYROSINE; ALPHA-SYNUCLEIN; ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELLS, CULTURED; DOPAMINE; DROSOPHILA; EMBRYO, NONMAMMALIAN; ENZYME INHIBITORS; GLUTATHIONE; GREEN FLUORESCENT PROTEINS; HOMEOSTASIS; HUMANS; INDOLES; MUTATION; NERVE DEGENERATION; PROLINE; RECEPTORS, DOPAMINE D1; TIME FACTORS; TYROSINE 3-MONOOXYGENASE; VESICULAR MONOAMINE TRANSPORT PROTEINS;

EID: 36248929304     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05929.x     Document Type: Article

References (44)

1. Abou-Sleiman, P.M., Muqit, M.M. Wood, N.W. (2006) Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat. Rev. Neurosci., 7, 207 219.
2. Auluck, P.K., Chan, H.Y., Trojanowski, J.Q., Lee, V.M. Bonini, N.M. (2002) Chaperone suppression of alpha-synuclein toxicity in a Drosophila model for Parkinson's disease. Science, 295, 865 868.
3. Bayer, T.A., Jakala, P., Hartmann, T., Egensperger, R., Buslei, R., Falkai, P. Beyreuther, K. (1999) Neural expression profile of alpha-synuclein in developing human cortex. Neuroreport, 10, 2799 2803.
4. Brand, A.H. Perrimon, N. (1993) Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development, 118, 401 415.
5. Budnik, V. White, K. (1988) Catecholamine-containing neurons in Drosophila melanogaster: distribution and development. J. Comp. Neurol., 268, 400 413.
6. Cao, S., Gelwix, C.C., Caldwell, K.A. Caldwell, G.A. (2005) Torsin-mediated protection from cellular stress in the dopaminergic neurons of C. elegans. J. Neurosci., 25, 3801 3812.
7. Chang, H.Y., Grygoruk, A., Brooks, E.S., Ackerson, L.C., Maidment, N.T., Bainton, R.J. Krantz, D.E. (2005) Overexpression of the Drosophila vesicular monoamine transporter increases motor activity and courtship but decreases the behavioral response to cocaine. Mol. Psychiatry, 11, 99 113.
8. Conway, K.A., Harper, J.D. Lansbury, P.T. Jr. (2000) Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry, 39, 2552 2563.
9. Cookson, M.R. (2005) The biochemistry of Parkinson's disease. Ann. Rev. Biochem., 74, 29 52.
10. Dauer, W. Przedborski, S. (2003) Parkinson's disease: mechanisms and models. Neuron, 39, 889 909.
11. Fahn, S. Sulzer, D. (2004) Neurodegeneration and neuroprotection in Parkinson disease. NeuroRx, 1, 139 154.
12. Friggi-Grelin, F., Coulom, H., Meller, M., Gomez, D., Hirsh, J. Birman, S. (2003a) Targeted gene expression in Drosophila dopaminergic cells using regulatory sequences from tyrosine hydroxylase. J. Neurobiol., 54, 618 627.
13. Friggi-Grelin, F., Iche, M. Birman, S. (2003b) Tissue-specific developmental requirements of Drosophila tyrosine hydroxylase isoforms. Genesis, 35, 175 184.
14. Fujisawa, H. Okuno, S. (2005) Regulatory mechanism of tyrosine hydroxylase activity. Biochem. Biophys. Res. Commun., 338, 271 276.
15. Giasson, B.I. Lee, V.M. (2003) Are ubiquitination pathways central to Parkinson's disease? Cell, 114, 1 8.
16. Goldstein, L.S.B. Fyrberg, E.A. (1994) Drosophila melanogaster: practical uses in cell and molecular biology. In Methods Cell Biol. 44. Academic Press, San Diego.
17. Greer, C.L., Grygoruk, A., Patton, D.E., Ley, B., Romero-Calderon, R., Chang, H.Y., Houshyar, R., Bainton, R.J., Diantonio, A. Krantz, D.E. (2005) A splice variant of the Drosophila vesicular monoamine transporter contains a conserved trafficking domain and functions in the storage of dopamine, serotonin, and octopamine. J. Neurobiol., 64, 239 258.
18. Hodges, D.D., Lee, D., Preston, C.F., Boswell, K.M., Hall, L.M. O'Dowd, D.K. (2002) tipE regulates Na+-dependent repetitive firing in Drosophila neurons. Mol. Cell. Neurosci., 19, 402 416.
19. Jakes, R., Spillantini, M.G. Goedert, M. (1994) Identification of two distinct synucleins from human brain. FEBS Lett., 345, 27 32.
20. Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J.T., Schols, L. Riess, O. (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. Nat. Genet., 18, 106 108.
21. Kumer, S.C. Vrana, K.E. (1996) Intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem., 67, 443 462.
22. Lotharius, J., Barg, S., Wiekop, P., Lundberg, C., Raymon, H.K. Brundin, P. (2002) Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line. J. Biol. Chem., 277, 38884 38894.
23. Lotharius, J. Brundin, P. (2002) Pathogenesis of Parkinson's disease: dopamine, vesicles and α-synuclein. Nat. Rev. Neurosci., 3, 1 11.
24. Lykkebo, S. Jensen, P.H. (2002) Alpha-synuclein and presynaptic function: implications for Parkinson's disease. Neuromolec. Med., 2, 115 129.
25. Maguire-Zeiss, K.A., Short, D.W. Federoff, H.J. (2005) Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease? Brain Res. Mol. Brain Res., 134, 18 23.
26. Maroteaux, L., Campanelli, J.T. Scheller, R.H. (1988) Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci., 8, 2804 2815.
27. Moore, D.J., West, A.B., Dawson, V.L. Dawson, T.M. (2005) Molecular pathophysiology of Parkinson's disease. Ann. Rev. Neurosci., 28, 57 87.
28. Mosharov, E.V., Staal, R.G., Bove, J., Prou, D., Hananiya, A., Markov, D., Poulsen, N., Larsen, K.E., Moore, C.M., Troyer, M.D., Edwards, R.H., Przedborski, S. Sulzer, D. (2006) Alpha-synuclein overexpression increases cytosolic catecholamine concentration. J. Neurosci., 26, 9304 9311.
29. Neckameyer, W.S. Quinn, W.G. (1989) Isolation and characterization of the gene for Drosophila tyrosine hydroxylase. Neuron, 2, 1167 1175.
30. Olanow, C.W. Tatton, W.G. (1999) Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci., 22, 1213 1244.
31. Park, S.S. Lee, D. (2006) Selective loss of dopaminergic neurons and formation of Lewy body-like aggregations in alpha-synuclein transgenic fly neuronal cultures. Eur. J. Neurosci., 23, 2908 2914.
32. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E.S., Chandrasekharappa, S., Athanassiadou, A., Papapetropopoulos, T., Johnson, W.G., Lazzarini, A.M., Duvoisin, R.C., DiIorio, G., Golbe, L.I. Nussbaum, R.L. (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science, 276, 2045 2047.
33. Salvaterra, P.M. Kitamoto, T. (2001) Drosophila cholinergic neurons and processes visualized with Gal4/UAS-GFP. Brain Res. Gene Expr. Patterns, 1, 73 82.
34. de Silva, H.R., Khan, N.L. Wood, N.W. (2000) The genetics of Parkinson's disease. Curr. Opin. Gen. Dev., 10, 292 298.
35. Sulzer, D. (2007) Multiple hit hypotheses for dopamine neuron loss in Parkinson's disease. Trends Neurosci., 30, 244 250.
36. Sun, B., Xu, P. Salvaterra, P.M. (1999) Dynamic visualization of nervous system in live Drosophila. Proc. Natl Acad. Sci. USA, 96, 10438 10443.
37. Takahashi, N., Miner, L.L., Sora, I., Ujike, H., Revay, R.S., Kostic, V., Jackson-Lewis, V., Przedborski, S. Uhl, G.R. (1997) VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc. Natl Acad. Sci. USA, 94, 9938 9943.
38. Vekrellis, K., Rideout, H.J. Stefanis, L. (2004) Neurobiology of alpha-synuclein. Mol. Neurobiol., 30, 1 21.
39. Vie, A., Cigna, M., Toci, R. Birman, S. (1999) Differential regulation of Drosophila tyrosine hydroxylase isoforms by dopamine binding and cAMP-dependent phosphorylation. J. Biol. Chem., 274, 16788 16795.
40. Wersinger, C., Prou, D., Vernier, P. Sidhu, A. (2003) Modulation of dopamine transporter function by alpha-synuclein is altered by impairment of cell adhesion and by induction of oxidative stress. FASEB J., 17, 2151 2153.
41. Wu, M.N., Fergestad, T., Lloyd, T.E., He, Y., Broadie, K. Bellen, H.J. (1999) Syntaxin 1A interacts with multiple exocytic proteins to regulate neurotransmitter release in vivo. Neuron, 23, 593 605.
42. Xu, J., Kao, S.Y., Lee, F.J., Song, W., Jin, L.W. Yankner, B.A. (2002) Dopamine-dependent neurotoxicity of α-synuclein: a mechanism for selective neurodegeneration in Parkinson disease. Nat. Med., 8, 600 606.
43. Yu, S., Ueda, K. Chan, P. (2005) Alpha-synuclein and dopamine metabolism. Mol. Neurobiol., 31, 243 254.
44. Zarranz, J.J., Alegre, J., Gomez-Esteban, J.C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atares, B., Llorens, V., Gomez Tortosa, E., del Ser, T., Munoz, D.G. de Yebenes, J.G. (2004) The new mutation, E46K, of alpha-synuclein causes Parkinson and Lewy body dementia. Ann. Neurol., 55, 164 173.